New Breakthrough or Setback? What’s Next for Acelyrin Inc.?
In recent developments, Acelyrin Inc. faces a mixed bag of news as it navigates clinical and financial territories. The company’s clinical trial for its drug, izokibep, aimed at treating uveitis, did not meet its primary goal. When compared with a placebo, both